Standard BioTools Inc.
LAB
$1.01
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 558.96% | 155.59% | -3.67% | -28.53% | 23.59% |
| Total Depreciation and Amortization | -73.36% | 231.00% | -60.02% | 91.19% | -83.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3,164.88% | -50.36% | 34.92% | -16.58% | 1,969.90% |
| Change in Net Operating Assets | 46.37% | -6,666.88% | -56.23% | 106.90% | -294.57% |
| Cash from Operations | -3,815.71% | 94.64% | -7.42% | 31.75% | -115.40% |
| Capital Expenditure | -19.75% | 46.28% | 53.05% | 62.66% | -49.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,168.14% | -30.53% | -119.72% | 49.36% | -35.46% |
| Cash from Investing | 2,476.74% | -20.34% | -124.29% | 88.07% | -43.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -89.54% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | 6.35% | -12.50% | 44.00% | -334.78% | -2.22% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -106.45% | 653.57% | -203.70% | 334.78% | 99.92% |
| Foreign Exchange rate Adjustments | 215.00% | 50.74% | -125.76% | 120.73% | 233.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,759.79% | 70.17% | -477.58% | 150.39% | 64.41% |